Abiomed (ABMD) Tops Q2 EPS by 35c
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Selling, general and administrative: 53.09M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Selling, general and administrative: 53.09M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Abiomed (NASDAQ: ABMD) reported Q2 EPS of $1.09, $0.35 better than the analyst estimate of $0.74. Revenue for the quarter came in at $181.8 million versus the consensus estimate of $175.22 million.
GUIDANCE:
Abiomed sees FY2019 revenue of $765-770 million, versus prior of $755-$770 million and the consensus of $770.52 million.
For earnings history and earnings-related data on Abiomed (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Four Tree Island Advisory calls DoubleDown $11.25 offer too low
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
